Cadence’s Post

Our first peer-reviewed study! We showed how remote monitoring greatly improves clinical outcomes and costs of care for congestive heart failure patients with reduced ejection fraction, in part, by using their routinely collected physiologic data to prescribe and titrate four crucial drugs. #cardiology #heartfailure #physicians #medicine

A new study by University of Birmingham has shown that a targeted training programme for healthcare professionals can improve part of the care of patients with atrial fibrillation (AF), a common heart rhythm disorder. The STEEER-AF cluster-randomised trial was presented last weekend at the European Society of Cardiology (ESC) Congress 2024 in a hotline session. Led by Professor Dipak Kotecha, the study found that adherence to existing AF treatment guidelines was generally low across Europe. However, a short, structured educational programme for healthcare professionals led to a 51% improvement in guideline adherence for heart rhythm control, although not a significant improvement for stroke prevention. Improved adherence to guidelines means better care and outcomes for patients with AF. Find out more: https://lnkd.in/eBpYCJzh #research #medicalresearch #birmingham #atrialfibrillation #cardiology #cardiologyresearch

This was a prespecified subgroup analysis of the BETTER CARE-HF (Building Electronic Tools to Enhance and Reinforce Cardiovascular Recommendations for Heart Failure) cluster-randomized trial, which compared effectiveness of an alert vs message vs usual care on prescribing of mineralocorticoid antagonists (MRAs). The trial included adults with HFrEF seen in cardiology offices who were eligible for and not prescribed MRAs. Visit volume was defined at the cardiologist-level as number of visits per 6-month study period (high = upper tertile vs non-high = remaining). Study showed that An EHR-embedded alert increased prescribing by >5-fold among patients seen by high-volume cardiologists. These findings support use of EHR alerts, especially in busy practice settings. (Building Electronic Tools to Enhance and Reinforce Cardiovascular Recommendations for Heart Failure

Congratulations to our cardiology researchers who have recruited more patients into a multinational heart trial than months they have been open as a recruiting site ❤️ Interventional Cardiologist Dr Aetesam-ur-Rahman and Clinical Trials Assistant Franek Skalbania received special commendation for their success in recruiting patients into the EASY-AS trial. The study, which is being funded by the British Heart Foundation in the UK, is looking to find out whether early heart valve replacement leads to better outcomes after five years in patients with aortic stenosis. Once concluded, the findings could change the way patients with #aortic stenosis are treated. Aortic stenosis is a common and serious heart problem, which causes the heart valve to narrow and not fully open. Symptoms include shortness of breath and chest pain. The Sheffield team are one of 100 cardiology sites across the globe taking part in the trial. More here: https://lnkd.in/dZEf4yWQ #cardiology #heartdisease #heartvalves #TAVI #tavr #tmvr #aorticstenosis  #nhsresearchsaveslives

https://lnkd.in/gcQ75fBu Article title: Antithrombotic therapy and clinical characteristics of patients hospitalized for nonvalvular atrial fibrillation in Galician internal medicine clinics Author(s): José Manuel Cerqueiro-González*; Elena Fernández-Bouza; Manuel Lorenzo López-Reboiro; Paula Pesqueira-Fontán; Patricia Vázquez-Rodríguez; Ignacio Novo-Veleiro; Emilio Casariego-Vales Journal: Journal of Cardiovascular Medicine and Cardiology Journal ISSN: 2455-2976 Abstract: This was a multicenter, prospective, observational study that assessed the characteristics of patients with Nonvalvular Atrial Fibrillation (NVAF) admitted to internal medicine units in Galicia, Spain, as well as the antithrombotic treatment prescribed prior to hospital admission. Demographic characteristics, cardiovascular risk factors, polypharmacy, comorbidity, functional status and reasons for hospitalization were recorded for patients with NVAF admitted between January 2016 and January 2017. The antithrombotic treatment received by patients prior to hospital admission and the reasons for using this treatment were also analyzed. #CoronaryArteryDiseases #ValvularHeartDisease #Electrophysiology #CardiacElectrophysiology #Echocardiography #InterventionalCardiology #ClinicalCardiology #NuclearCardiology #AcuteCoronarySyndromes #ArrhythmiaEP #CVImaging #CVDPrevention #CardiacArrhythmias #Peertechz #PeertechzPublications #OpenAccess #ScientificJournals #PeerReviewedJournals #OpenAccessPublishers #CardiacPhysiology #CardiacRegeneration #CardiacRehabilitation #Cardiomyopathies #CardiovascularDrugs #CardiovascularTherapy #CardiovascularAnatomy #CongenitalHeartDefects 

📚 #ReadoftheWeek: Enhancing Cardiac Rehabilitation with eHealth Discover the findings on the effectiveness of #eHealth cardiac rehabilitation for coronary heart disease patients. This systematic review and meta-analysis, spanning 14 trials and about 1800 participants, highlights the significant benefits of eHealth cardiac rehabilitation, including increased physical activity duration, daily steps, quality of life, and reduced re-hospitalization rates. By analyzing program design elements, such as delivery mode and intervention content, the study identifies comprehensive empowerment strategies and tele-monitoring as key components leading to more favorable treatment outcomes. These insights pave the way for future research and inform cardiovascular nurses on evidence-based practices in promoting eHealth cardiac rehabilitation. Read the paper here: https://lnkd.in/dB7kvnrS #CardiacRehabilitation #HealthOutcomes #ResearchInsights

📢 Review Sharing-Vol. 25 No. 2 💕 Title: Left Main Coronary Artery Disease: A Contemporary Review of Diagnosis and Management 🤵 Authors: Muzamil Khawaja, M.D., Michael Britt, Muhammad Asad Khan, Uzair Munaf, Hassaan Arshad, MD, Rehma Siddiqui, Hafeez Ul Hassan Virk, Mahboob Alam, Chayakrit Krittanawong, MD, FACC,* 🔔 Full Text: https://lnkd.in/gq65BY4s 🔑 Keywords: left main coronary artery disease; percutaneous coronary intervention; coronary artery bypass grafting; revascularization 😎Welcome to your reading! #Cardiovascular #HeartHealth #CVD #HeartDisease #HealthyHeart #HeartCare #HeartAwareness #StrokePrevention #HeartAttack #Cardiology #HeartFailure #HeartResearch #BloodPressure #Cholesterol #Atherosclerosis #HeartRisk #HeartAwarenessMonth #HeartMonth #PreventHeartDisease #HealthyLifestyle #PediatricCardiology #CardiacHealth #RareDisease #CardiacTumors #MedicalResearch #HealthcareAwareness #HeartHealth #PediatricHealth #Cardiology #HeartDisease #TumorResearch #MedicalScience #CardiovascularHealth

Dr. Dhanunjaya (DJ) Lakkireddy MD, MBA is doing great things right here in the Kansas City area. He recently led a highly skilled team in cardiology at Overland Park Regional Medical Center with new technology in treating atrial fibrillation. This new procedure aims to reduce potential complications, including collateral cardiac damage and cell death, that have been seen in previous older procedures. Dr. Lakkireddy is also helping to lead the charge in treating metabolic disease and obesity as a disease. Metabolic dysfunction is at the core of heart disease which remains the leading cause of death in America. #atrialfibrillation #heartdisease #metabolicdisease #metabolichealth #hearthealth #obesity #obesitymedicine #obesitytreatment Courtney Younglove, M.D., FOMA, FACOG, DABOM Maribeth Orr, D.O., DABFM, DABOM Read the full story here: 👇 https://lnkd.in/ggJBj6JZ

I am pleased to announce that our multicenter research letter is now published in Amyloid!  We evaluated the correlation between different cardiac tracer uptake and wall thickness on echocardiography. We established that: 1.        That there is no correlation between cardiac tracer uptake and wall thickness; 2.        Approximately 10% of patients with ATTR-CM have no increased wall thickness, indicating that in patients with unexplained heart failure and “red flags” of ATTR-CM, ATTR-CM should be thought of irrespective of wall thickness; and 3.        There is a moderate correlation between LV posterior and IVSd thickness (R=0.69), showing that ATTR-CM can be present in patients with both symmetric as well as asymmetric left ventricular hypertrophy. ATTR-CM can be present in patients with unexplained heart failure and “red flags” irrespective of the presence of (symmetric/asymmetric) left ventricular hypertrophy. We believe that this research letter helps us move forward to ultimately diagnose and subsequently treat patients with ATTR-CM as early as possible. This collaborative effort could not have been made possible without the help of:  Anouk Achten, Manon van der Meer, Peter-Paul Zwetsloot, Sandra Sanders-van Wijk, Pim van der Harst, J. Peter van Tintelen, Anneline te Riele, Vanessa Van Empel, Christian Knackstedt, M.D., Ph.D., FESC, Marish Oerlemans #CardiacAmyloidosis #ATTR-CM Circulatory Health UMC Utrecht

As #ACC24 comes to a close, it is amazing to see the progress taking place. The American College of Cardiology continues to focus on #healthequity, #pointofcaresolutions, and #healthcaretransformation. Innovative Point of Care technologies are becoming a reality and Healthcare Professionals are increasingly acknowledging the tools needed to support sustainable and equitable cardiovascular care. The Acarix #CADScor System aligns with this shift by providing point of care risk stratification for stable chest pain patients with significant potential for cost savings. Over the weekend, Dr. Suzanne Baron presented a cost-effectiveness analysis that demonstrated substantial cost savings when used in stable low risk patients presenting to the Emergency Department. We know inappropriate testing is a reality when hospital staff are hesitant to discharge these patients. Use of a “CADScor First” approach could result in substantial #costsavings, as much as $1,778 per patient. Thank you to those who attended Dr. Baron’s presentation and stopped by our booth to learn about the value the CADScor System can provide during this transformative time in patient care. www.acarix.com #acarix American College of Cardiology #ED #ER #valuebasedcare #CAD #RiskStratification #emergencyroom #emergencydepartment C. Michael Gibson, M.S., M.D. #coronaryarterydisease #valuepropostion Sam Basta, MD, MMM, FACP, CPE Cardiovascular Business American Academy of Emergency Medicine (AAEM) American Academy Of Emergency Nurse Practitioner #UrgentCare Urgent Care Association UnitedHealth Group UnitedHealthcare BlueCross BlueShield of Tennessee BlueCross BlueShield of South Carolina Blue Cross Blue Shield of Michigan Excellus BCBS Health Care Service Corporation Aetna, a CVS Health Company CVS Health Signify Health Humana Cigna Healthcare The Cigna Group Blue Cross and Blue Shield of Oklahoma Blue Cross and Blue Shield of Texas Blue Cross and Blue Shield of Illinois Blue Cross and Blue Shield of Minnesota Blue Cross NC Blue Cross and Blue Shield of Montana Blue Cross and Blue Shield of New Mexico HCA Healthcare HCA Healthcare UK Vizient, Inc Banner Health